Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dalmark

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Acta Oncologica (Stockholm, Sweden)|January 1, 1990
Current status of epirubicin (Farmorubicin) in the treatment of solid tumoursH T Mouridsen, C Alfthan, L Bastholt, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Multiple-dose pharmacokinetics of epirubicin at four different dose levels: studies in patients with metastatic breast cancerP Jakobsen, E Steiness, L Bastholt, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
A randomized study of epirubicin at four different dose levels in advanced breast cancer. Feasibility of myelotoxicity prediction through single blood-sample measurementP Jakobsen, L Bastholt, M Dalmark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996
Modulation of high-dose infusional fluorouracil by low-dose methotrexate in patients with advanced or metastatic colorectal cancer: final results of a randomized European Organization for Research and Treatment of Cancer StudyG Blijham, T Wagener, J Wils, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Dose-response relationship of epirubicin in the treatment of postmenopausal patients with metastatic breast cancer: a randomized study of epirubicin at four different dose levels performed by the Danish Breast Cancer Cooperative GroupL Bastholt, M Dalmark, S B Gjedde, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Acta Oncologica (Stockholm, Sweden)|January 1, 1990
Current status of epirubicin (Farmorubicin) in the treatment of solid tumoursH T Mouridsen, C Alfthan, L Bastholt, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Multiple-dose pharmacokinetics of epirubicin at four different dose levels: studies in patients with metastatic breast cancerP Jakobsen, E Steiness, L Bastholt, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
A randomized study of epirubicin at four different dose levels in advanced breast cancer. Feasibility of myelotoxicity prediction through single blood-sample measurementP Jakobsen, L Bastholt, M Dalmark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996
Modulation of high-dose infusional fluorouracil by low-dose methotrexate in patients with advanced or metastatic colorectal cancer: final results of a randomized European Organization for Research and Treatment of Cancer StudyG Blijham, T Wagener, J Wils, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Dose-response relationship of epirubicin in the treatment of postmenopausal patients with metastatic breast cancer: a randomized study of epirubicin at four different dose levels performed by the Danish Breast Cancer Cooperative GroupL Bastholt, M Dalmark, S B Gjedde, et al.
Pageof 4